Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yunnan Baiyao Aerosol for Acute Unilateral Ankle/Foot Soft Tissue Injury
ChiCTR2500111008Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Yunnan Baiyao in Ankle sprain and Soft tissue injury of the foot (STI) (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Foot and Ankle Ability Measure - Activities of Daily Living (FAAM-ADL) score change from baseline after end of medication. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
Yunnan Baiyao
03
Conditions
Ankle sprainSoft tissue injury of the foot (STI)
Beyond the preview
Go deeper on ChiCTR2500111008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111008.